LABCORP HOLDINGS INC. 10-Q

ITEM 5. OTHER INFORMATION Insider Adoption or Termination of Trading Arrangements: During the fiscal quarter ended June 30, 2025, none of the Company’s directors or officers informed it of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408, except as described in the table below: Name and Title Date Adopted Character of Trading Agreement Aggregate Number of Shares of Common Stock to be (Sold) Purchased Pursuant to Trading Agreement Duration Adam H. Schechter May 8, 2025 Rule 10b5-1 Trading Arrangement Up to ( 27,273 ) (1) 11/20/2026 (2) President and Chief Executive Officer (1) The figure presented represents shares of Common Stock previously acquired from equity award vesting events. (2) This trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales on the respective order entry date or (b) the date listed in the table. 34 TABLE OF CONTENTS ITEM 6. EXHIBITS (a) 10.1 Fourth Amend e d and Restated Credit Agreement dated as of June 27, 2025, (originally dated as of April 30, 2021), among the Company, Bank of America, N.A., as administrative agent, and lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 27 , 2025). 10.2+ Lab corp Holdings Inc 20 25 Omnibus Incentive Plan (incorporated by reference herein to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 1 5 , 20 25 ). 10.3+ Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan (incorporated by reference herein to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on May 15, 2025). 22.1* Subsidiary Issuers of Guaranteed Securities 31.1* Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) 31.2* Certification by the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) 32** Written Statement of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350) 101.INS* Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH* Inline XBRL Taxonomy Extension Schema 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase 104 Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101) * filed herewith ** furnished herewith + Management contracts or compensatory plans or arrangements 35 TABLE OF CONTENTS SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. LABCORP HOLDINGS INC. Registrant By: /s/ ADAM H. SCHECHTER Adam H. Schechter President and Chief Executive Officer (Principal Executive Officer) By: /s/ JULIA A. WANG Julia A. Wang Executive Vice President and Chief Financial Officer (Principal Financial Officer) Dated: August 1, 2025 36